Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8924 |
High Similarity |
NPD7819 |
Suspended |
0.8827 |
High Similarity |
NPD6959 |
Discontinued |
0.8562 |
High Similarity |
NPD7411 |
Suspended |
0.8528 |
High Similarity |
NPD7075 |
Discontinued |
0.8519 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8457 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8457 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8443 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8397 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.8397 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8387 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8387 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8323 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8323 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8303 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8302 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8302 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8302 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8302 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8302 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8294 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8282 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8272 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8272 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8242 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8204 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8176 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8171 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8141 |
Intermediate Similarity |
NPD6100 |
Approved |
0.8141 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8141 |
Intermediate Similarity |
NPD6099 |
Approved |
0.8118 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8118 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8118 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8107 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8101 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8084 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8081 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8077 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8077 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8035 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8024 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7988 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7988 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7987 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7977 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7975 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7963 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7955 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7955 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7949 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7949 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7944 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7943 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7937 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7935 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7931 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7911 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7911 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7904 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7886 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7857 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7848 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7841 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7826 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7811 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7805 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7798 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7797 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7791 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7791 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7791 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7784 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7758 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7758 |
Intermediate Similarity |
NPD920 |
Approved |
0.7751 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7736 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7722 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7714 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7697 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7692 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7684 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7683 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.767 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7658 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7658 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7654 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7637 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7636 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7624 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7622 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7614 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7607 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.758 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.758 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7578 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7578 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7578 |
Intermediate Similarity |
NPD5406 |
Approved |
0.753 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7526 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7514 |
Intermediate Similarity |
NPD919 |
Approved |
0.7513 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7468 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.746 |
Intermediate Similarity |
NPD6780 |
Approved |
0.746 |
Intermediate Similarity |
NPD6779 |
Approved |
0.746 |
Intermediate Similarity |
NPD6782 |
Approved |
0.746 |
Intermediate Similarity |
NPD6777 |
Approved |
0.746 |
Intermediate Similarity |
NPD6776 |
Approved |
0.746 |
Intermediate Similarity |
NPD6781 |
Approved |
0.746 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7452 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7442 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7436 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7436 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7435 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7435 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7435 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7416 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7416 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7407 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7394 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7386 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7384 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7384 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.738 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.738 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7377 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7368 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7358 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7355 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7351 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7342 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.733 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7326 |
Intermediate Similarity |
NPD37 |
Approved |
0.7317 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7314 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7314 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7306 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7306 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7306 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7306 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7302 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7299 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7299 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7299 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7296 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7296 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD9717 |
Approved |
0.729 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7282 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7277 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7261 |
Intermediate Similarity |
NPD2797 |
Approved |
0.725 |
Intermediate Similarity |
NPD411 |
Approved |
0.725 |
Intermediate Similarity |
NPD3764 |
Approved |
0.725 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7247 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7235 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7232 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7226 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7226 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7222 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7205 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7202 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7197 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7196 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7196 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7184 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7173 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7173 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7172 |
Intermediate Similarity |
NPD7801 |
Approved |
0.716 |
Intermediate Similarity |
NPD943 |
Approved |
0.716 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7152 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7151 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7135 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7135 |
Intermediate Similarity |
NPD8285 |
Discontinued |
0.7127 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7115 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7115 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7108 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD7236 |
Approved |
0.7097 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7097 |
Intermediate Similarity |
NPD17 |
Approved |
0.7097 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7078
|
Intermediate Similarity |
NPD9545 |
Approved |